(Q68140704)
Statements
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease (English)
Hervé P
P. Hervé
M. Flesch
P. Tiberghien
J. Wijdenes
E. Racadot
P. Bordigoni
E. Plouvier
J. L. Stephan
H. Bourdeau
1 June 1992